Skip to main content

Windward Bio Group AG

WWB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002145089

In the last 90 days, Windward Bio Group AG insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Windward Bio Group AG insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
2 insiders, $49.8M in total
Open-market sells
0 filings
Insiders trading
2
Net value
+$49.8M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Windward Bio Group AG, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Windward Bio Group AG
NameTitleLast reported holdingLast filingFilings, past year
Bonita David PDirector, 10% Owner7,097,483IndirectNov 18, 20262
OrbiMed Advisors LLCDirector, 10% Owner7,097,483IndirectNov 18, 20261
OrbiMed Capital GP IX LLCDirector, 10% Owner7,097,483IndirectNov 18, 20261
Stampacchia OtelloDirector2,669,260IndirectNov 18, 20262
Mufti Iqbal RasoolDirector–Nov 16, 20261
D'Augusta ClaudiaChief Financial Officer–Nov 16, 20261
Khwaja OmarChief Medical Officer–Nov 16, 20261
Santarelli LucaChief Executive Officer–Nov 16, 20261
Kapadia SandipDirector100,000Nov 16, 20261
Harris Kevin AndrewChief Operating Officer960,966Nov 16, 20261
Applebaum ScottChief Legal & Corp Dev Officer960,966Nov 16, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)5:12 PM ETNov 162 daysBonita David PDirector, 10% OwnerPPurchase+1.18M$17.00+$20.0M+221.3%1.71M afterDuplicate filing
Nov 18, 2026 (view filing)5:08 PM ETNov 162 daysOrbiMed Advisors LLC and 1 otherDirector, 10% OwnerPPurchase+1.18M$17.00+$20.0M+221.3%1.71M after
Nov 18, 2026 (view filing)4:30 PM ETNov 162 daysStampacchia OtelloDirectorPPurchase+1.75M$17.00+$29.8MNew position875.0K after2 lots